Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study
The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
Treatment for negative symptoms and cognitive deficits, core elements of schizophrenia, remains inadequate. Stimulation of the prefrontal cortex via transcranial magnetic stimulation (TMS) yields only moderate results, possibly due to limited stimulation depth. Deep-TMS enables deeper and wider stimulation than before. This preliminary study is the first to examine deep-TMS as a possible add-on treatment for negative symptoms and cognitive deficits of schizophrenia. The effect of 20 daily deep-TMS sessions (20 Hz, 120% motor threshold) over the prefrontal cortex of 15 patients indicated improvement in cognition and negative symptoms that was maintained at 2-wk post-treatment follow-up.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deep TMS (dTMS), utilizes H-coils to extend this stimulation to deeper targets, while also offering more favorable safety and tolerability profiles [6,100,101,102,103,104,105].”
Citations
Cites
Strafella, A. P., Paus, T., Barrett, J., & Dagher, A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-j0003.2001 · Cited by 1,058 · cited 2×
“It has been demonstrated that activation of the prefrontal cortex (PFC) modulates dopamine release (Strafella et al. 2001) which may underlie improvement of negative symptoms (Heimer et al.”
BackgroundLeucht, S., Pitschel-Walz, G., Abraham, D., & Kissling, W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00105-4 · Cited by 796 · cited 1×
“Negative symptoms and cognitive deficits are considered core symptoms of schizophrenia (Kuperberg & Heckers, 2000) and treatment for these indications remains inadequate (Keefe et al. 1999).”
BackgroundHypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients
Andreasen, N. C., O'Leary, D. S., Flaum, M., Nopoulos, P., Watkins, G. L., Ponto, L. L. B., & Hichwa, R. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08258-x · Cited by 597 · cited 1×
“Hypofrontality, particularly of DLPFC correlates with both negative symptoms and cognitive deficits (Andreasen et al. 1997) and has been suggested as a primary abnormality in the disorder (Weinberger et al. 1996).”
BackgroundTranscranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-Coil
Zangen, A., Roth, Y., Voller, B., & Hallett, M. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.11.008 · Cited by 473 · cited 1×
“Recently, a novel, deepTMS H1 coil was introduced in clinical studies, inducing a magnetic field with greater depth and distribution (Roth et al. 2007; Zangen et al. 2005).”
BackgroundSelf-citationPrefrontal function in schizophrenia: confounds and controversies
Weinberger, D. R., & Berman, K. F. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0135 · Cited by 413 · cited 2×
“Hypofrontality, particularly of DLPFC correlates with both negative symptoms and cognitive deficits (Andreasen et al. 1997) and has been suggested as a primary abnormality in the disorder (Weinberger et al. 1996).”
BackgroundPell, G. S., Roth, Y., & Zangen, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.10.003 · Cited by 406 · cited 1×
“High-frequency TMS was also shown to induce acute increases in neuronal excitability, and repeated sessions were shown to induce long-lasting effects (Pell et al. 2011).”
BackgroundSelf-citationRoth, Y., Amir, A., Levkovitz, Y., & Zangen, A. (2007) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e31802fa393 · Cited by 389 · cited 2×
“This version of the H coil is designed to stimulate deeper layers of the PFC, especially in the left hemisphere, and effectively reaches a depth of 3 cm without a significant increase of electric fields induced in superficial cortical regions (Roth et al. 2007).”
BackgroundSelf-citationEffects of Psychotropic Drugs on Seizure Threshold
Pisani, F., Oteri, G., Costa, C., Di Raimondo, G., & Di Perri, R. (2002) · Drug Safety · doi:10.2165/00002018-200225020-00004 · Cited by 352 · cited 1×
“It is important to note that antipsychotics lower the threshold for a seizure and can even induce seizures without rTMS (Pisani et al. 2002).”
BackgroundA Coil Design for Transcranial Magnetic Stimulation of Deep Brain Regions
Roth, Y., Zangen, A., & Hallett, M. (2002) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200208000-00008 · Cited by 326 · cited 1×
“Standard rTMS coils induce an effective field in depth of approximately 1 cm (Roth et al. 2002).”
BackgroundSelf-citationSchizophrenia and cognitive function
Kuperberg, G. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00068-4 · Cited by 289 · cited 1×
“Negative symptoms and cognitive deficits are considered core symptoms of schizophrenia (Kuperberg & Heckers, 2000) and treatment for these indications remains inadequate (Keefe et al. 1999).”
Background
Cited by
Deng, Z.-D., Lisanby, S. H., & Peterchev, A. V. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.02.005 · Cited by 1,073
“a variety of psychiatric and neurological disorders, including major depression [80e87], schizophrenia [88,89], dystonia [90], autism [91], pain relief [92], and chronic migraine [93].”
Coil design considerations for deep transcranial magnetic stimulation
Deng, Z.-D., Lisanby, S. H., & Peterchev, A. V. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.11.038 · Cited by 308
“…et al., 2010a,b; Harel et al., 2011; Rosenberg et al., 2011a; Isserles et al., 2011; Harel et al., 2012; Bersani et al., 2013a), schizophrenia (Levkovitz et al., 2011a; Rosenberg et al., 2011b), dystonia (Kranz et al., 2010), autism (Enticott et al., 2011; Krause et al., 2012), pain…”
BackgroundIsserles, M., Shalev, A. Y., Roth, Y., Peri, T., Kutz, I., Zlotnick, E., & Zangen, A. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.07.008 · Cited by 260
“[23,24]) and bipolar [25] depressive patients, as well as in schizophrenic patients [26] further indicated on the safety and effectiveness of DTMS utilizing the H-coil.”
MethodSelf-citationCan noninvasive brain stimulation enhance cognition in neuropsychiatric disorders?
Demirtas-Tatlidede, A., Vahabzadeh-Hagh, A. M., & Pascual-Leone, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.020 · Cited by 236
“On the other hand, two open studies, which performed deeper stimulation via the use of double-cone and H-coils reported improvement of several cognitive domains (Cohen et al., 1999; Levkovitz et al., 2011).”
Kaster, T. S., Daskalakis, Z. J., Noda, Y., Knyahnytska, Y., Downar, J., Rajji, T. K., Levkovitz, Y., Zangen, A., Butters, M. A., Mulsant, B. H., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0121-x · Cited by 174
Self-citation
Metadata
- Authors
- Levkovitz, Y., Rabany, L., Harel, E. V., & Zangen, A.
- Affiliations
- Tel Aviv University (IL)
- Weizmann Institute of Science (IL)
- Corresponding author
- Levkovitz, Yechiel
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08
- Volume
- 14
- Issue
- 7
- Pages
- 991-996
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2106330029
- Cited by
- 87
- References
- 28
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 8 · 2014: 15 · 2013: 7 · 2012: 9
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- deep transcranial magnetic stimulation, schizophrenia, negative symptoms, cognitive impairment, prefrontal cortex stimulation, adjunctive therapy, feasibility
- MeSH terms
- Adolescent, Adult, Aged, Cognition Disorders, Combined Modality Therapy, Feasibility Studies, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Schizophrenia, Schizophrenic Psychology, Antipsychotic Agents, Prefrontal Cortex, Transcranial Magnetic Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study. https://app.cochat.ai/papers/10.1017/s1461145711000642
- The paper
- Levkovitz, Y., Rabany, L., Harel, E. V., & Zangen, A. (2011). Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study. International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145711000642
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.